MedTrace Logo

Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars

NCT03264573 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-08-29

No results posted yet for this study

Summary

The Objectives of this randomized controlled trial aiming to establishing a protocol of post scar revision care and to Study the effect of PRP and/or Adipose derived Mesenchymal Stem cell injection in improvement of atrophic scar after scar revision.

Conditions

  • Atrophic Scar

Interventions

BIOLOGICAL

Stem cell

after scar revision PRP is injected intradermally, also adipose derived mesenchymal stem cells

DEVICE

MSCs

manual separation of platelets rich plasma and undifferentiated mesenchymal stem cells

Sponsors & Collaborators

  • M.A. Eloteify

    collaborator UNKNOWN

  • Ahmed Kamal Osman

    collaborator UNKNOWN

  • G.M. Hafsa

    collaborator UNKNOWN

  • Heba Mohamed Saad Eldien

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-02-28
Completion
2017-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03264573 on ClinicalTrials.gov